Clinical trial
Safety and Dose Escalating Study of Oral Sodium Phenylbutyrate in Subjects With Amyotrophic Lateral Sclerosis
NCT00107770 is registered in ClinicalTrials.gov with US Department of Veterans Affairs as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Dose Escalating Study of Oral Sodium Phenylbutyrate in Subjects With Amyotrophic Lateral Sclerosis
- Lead sponsor
- US Department of Veterans Affairs
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- April 30, 2005
- Completion date
- September 30, 2007
- Enrollment
- 40 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.